Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 3.5 Contact Hours.
Acknowledgement of Commercial Support
This activity is supported by educational grants from AstraZeneca, Biocept, Inc., Foundation Medicine, Inc., Genomic Health, Guardant Health, and Novartis Pharmaceuticals Corporation.
Precision Medicine Through Plasma: Using Liquid Biopsies in Contemporary Oncology Care
117 West 46th Street
New York, NY
Successful patient selection and implementation of tumor interrogation methods, including emerging technologies such as liquid biopsies, are essential to providing timely, accurate characterization of different types of solid tumors, which can have a tremendous influence on treatment selection, and ultimately, patient outcomes. Precision Medicine Through Plasma: Using Liquid Biopsies in Contemporary Oncology Care is being launched to address the rapidly evolving science and associated therapeutic developments resulting from the emergence of novel testing strategies such as liquid biopsies. In this half-day symposium, key experts in lung, breast, and gastrointestinal malignancies will provide an overview of the latest clinical data on liquid biopsies, followed by detailed case discussions among a multidisciplinary faculty. Ample question-and-answer time will also be provided for attendees to interact directly with the expert faculty.
Key topics to be addressed include:
- The importance of testing, sequencing, and advanced genomics
- Differences regarding various modalities of testing, including the appropriate clinical utility of liquid biopsy
- Considerations for interpreting the results of liquid-based molecular testing
- Potential application in the clinic, from diagnosis through treatment in multiple lines of therapy
This educational activity is intended for medical oncologists, pathologists, and fellows who treat patients with cancer. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of cancer are also invited to participate. 2018-12-02 00:00:00
- Compare the relative strengths and limitations of liquid biopsy against those of conventional tissue biopsy
- Identify the scientific foundations of liquid biopsy technology
- Contrast available and emerging testing technologies with respect to sensitivity, specificity, and clinical applications for patients with cancer
- Appraise clinical evidence pertaining to specific testing modalities that may help to individualize treatment protocols for patients with cancer
Chair:Benjamin P. Levy, MD
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Sibley Memorial Hospital
You must be logged in to PER to register for this meeting
Or Register for PER now